SEC Filing Summary: BioSig Technologies, Inc. (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on January 6, 2021. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The report serves as a Regulation FD disclosure regarding an upcoming investor presentation.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on a specific event and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces a scheduled corporate event.
Guidance, Outlook, and Management Commentary
- Event Announcement: Kenneth L. Londoner, Chairman and CEO, will present live at the Sidoti Winter 2021 Investor Conference on Wednesday, January 13, 2021, at 2:30 PM ET.
- Legal Disclaimer: The Company explicitly states it undertakes no obligation to update, supplement, or amend the materials attached. The information is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings.
- Materiality: The Company notes that furnishing this information is not intended to constitute a determination that the information is material or required by Regulation FD.
Key Facts for Investor Verification
- Verify the correct registrant name is BioSig Technologies, Inc., as the input metadata incorrectly referenced "Streamex Corp."
- Confirm the presentation details: Sidoti Winter 2021 Investor Conference, January 13, 2021, 2:30 PM ET.
- Note that this filing contains no financial data; investors should refer to the most recent 10-K or 10-Q for financial metrics.
- Review the attached press release (Exhibit 99.1) for any additional context not summarized in the 8-K body.